KRAS and pancreatic neoplasm: To further evaluate the specificity of TCR-001, we cocultured TCR-001–transduced allogeneic T cells with human pancreatic cancer cell lines naturally expressing KRAS G12 mutations (Figure 4B) with or without HLA-A*11:01 transfection (Supplemental Figure 6).